BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20446263)

  • 21. Complement component C6 deficiency in a Spanish family: implications for clinical and molecular diagnosis.
    Moya-Quiles MR; Bernardo-Pisa MV; Martínez P; Gimeno L; Bosch A; Salgado G; Martínez-Banaclocha H; Eguia J; Campillo JA; Muro M; Vidal-Bugallo JB; Alvarez-López MR; García-Alonso AM
    Gene; 2013 May; 521(1):204-6. PubMed ID: 23537992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.
    Franco-Jarava C; Comas D; Orren A; Hernández-González M; Colobran R
    Clin Exp Immunol; 2017 Aug; 189(2):226-231. PubMed ID: 28369827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal meningitis in familial deficiency of the fifth component of complement.
    Peter G; Weigert MB; Bissel AR; Gold R; Kreutzer D; McLean RH
    Pediatrics; 1981 Jun; 67(6):882-6. PubMed ID: 6785713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
    Packman CH; Rosenfeld SI; Weed RI; Leddy JP
    J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of three new mutations causing C5 deficiency in two non-related families.
    López-Lera A; Garrido S; de la Cruz RM; Fontán G; López-Trascasa M
    Mol Immunol; 2009 Jul; 46(11-12):2340-7. PubMed ID: 19414197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hereditary complement deficiency in Tunisian adults with purulent meningitis].
    Abdelmalek R; Kallel Sallemi M; Zerzri Y; Kilani B; Laadhar L; Kanoun F; Tiouiri Benaissa H; Ghoubantini A; Ammari L; Makni S; Ben Chaabane T
    Med Mal Infect; 2011 Apr; 41(4):206-8. PubMed ID: 21195566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement deficiency syndromes and bacterial infections.
    Veitch J; Love C; Chaudhuri AK; Whaley K
    Prog Brain Res; 1983; 59():69-80. PubMed ID: 6665131
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of C5 deficiency with polyarthritis].
    Mimori M; Yamauchi I; Nishimura Y; Takada K; Inai S
    Rinsho Byori; 1992 Jun; 40(6):660-4. PubMed ID: 1513039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complement deficiencies and meningococcal disease in The Netherlands].
    Swart AG; Fijen CA; te Bulte MT; Daha MR; Dankert J; Kuijper EJ
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1147-52. PubMed ID: 8316311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of complement in anti-bacterial defence.
    D'Amelio R; Biselli R
    Ann Ital Med Int; 1994; 9(3):173-7. PubMed ID: 7946895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews.
    Zimran A; Rudensky B; Kramer MR; Tedesco F; Ehrenfeld M; Raz R; Greif Z; Gelber M; Lishner M; Golan E
    Q J Med; 1987 Apr; 63(240):349-58. PubMed ID: 3685247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combined-heterozygous deficiency of complement C7 in a patient with recurrent meningitis].
    Schirinzi R; Lantin JP; Frémeaux-Bacchi V; Schifferli JA; Trendelenburg M
    Med Klin (Munich); 2006 Aug; 101(8):655-8. PubMed ID: 16896572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement component C5 and C6 mutation screening indicated in meningococcal disease in South Africa.
    Owen EP; Leisegang F; Whitelaw A; Simpson J; Baker S; Würzner R; Potter P; Orren A
    S Afr Med J; 2012 May; 102(6):525-7. PubMed ID: 22668955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.
    Mak LW
    Clin Exp Immunol; 1978 Mar; 31(3):419-25. PubMed ID: 657587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum complement profile in human leprosy and its comparison with immune complex diseases.
    Saha K; Chakraborty AK
    Int J Lepr Other Mycobact Dis; 1977; 45(4):327-37. PubMed ID: 147246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.